Blow Fill Seal Technology Market Analysis
Blow-Fill-Seal (BFS) technology is a manufacturing technique used to produce small, (0.1mL) and large volume, (500mL +) liquid-filled containers. Originally developed in Europe in the 1930s, it was introduced in the United States in the 1960s, but over the last 20 years it has become more prevalent within the pharmaceutical industry and is now widely considered to be the superior form of aseptic processing by various medicine regulatory agencies including the U.S. Food and Drug Administration (FDA) in the packaging of pharmaceutical and healthcare products.
In the global blow fill seal technology market, the North America market has a leading position and is etimated to see a steady CAGR of 6.97% during the period of 2017-2025.
To learn more about this report, Download a free Sample Copy
The global Blow Fill Seal Technology market was valued at 2520 million US$ in 2018 and will reach 4500 million US$ by the end of 2025, growing at a CAGR of 7.5% during 2019-2025.
This report focuses on Blow Fill Seal Technology volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blow Fill Seal Technology market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blow Fill Seal Technology in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blow Fill Seal Technology manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
- Unither Pharmaceuticals
- Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH
- Catalent
- Curida
- Unipharma
- Weiler Engineering
- GlaxoSmithKline plc.
- Takeda Pharmaceuticals International AG
- Nephron Pharmaceuticals Corporation
- Horizon Pharmaceuticals
- Brevetti Angela S.R.L.
- Recipharm AB